ABOUT AUTHORS
Steffi Jerry Mammen,
Inamdar Multispecialty Hospital,
Pune,
Maharashtra, India steffi.thomas@ymail.com
Abstract:
The reality that medical treatment can harm patients is one that the healthcare community has had to come to, in terms with over recent years. Adverse events associated with medication errors are chief causes among them. A medication error is an error which can be defined as any discrepancy between the prescriber's interpretable medication order and what was administered to a patient. Prescribing & drug administration appears to be associated with greatest number of errors.
To ensure patient safety& provide better health services, medication errors should be curbed. India is still lacking the regulatory system for the control of medication errors.
Therefore, a stringent regulatory set up should be established to reduce medication errors. Awareness among the health-care professionals regarding medication errors may be the major factor in the establishment of a successful regulatory system. Some of them might be aware but reporting is rare due to many factors such as miscommunication, fear of punishment, potential termination from job, failure to comply with the policies etc.
Reporting will disclose medication errors, could trigger warnings, but should not create an unhealthy atmosphere post reporting, and acknowledging the facts and working on it could help prevent medication errors as all of health care domain are working for patient safety at the end.
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.
Harman finochem limited is a leading manufacturer of "active pharmaceutical ingredients" situated in Mumbai, India, exporting api globally. The manufacturing facilities comply to cgmp requirements and have been audited by usfda and who Gmp. Besides this, the company has also been accredited by various other regulatory authorities such as cos from edqm, pharmaceutical inspection convention (pic) member countries, tga-Australia.
We are one of the fast growing Pharma company spreaded all over India. Specialized in Gynaecology products,IVF and fertility products. Head office based at Bangalore.
Apotex Research Pvt. Ltd. is a wholly owned subsidiary of Apotex Inc. Canada which is a number one generic pharma co. in Canada. The position is for Bangalore location which has an R&D Centre, Manufacturing and a Bioequivalence Centre.
NutriSynapzz markets innovative nutraceuticals with breakthrough concepts to medical doctors across the country. We are looking out for fresh graduates and also experienced marketing executives (1 to 2 years) who are go-getters, want to create great wealth for themselves and transform themselves into the best knowledge workers. The only pre-requisite is the ability to be fluent in spoken english. We offer the best salaries, allowances and performance based incentives as per industry standards. Invest in yourself. Join Nutri Synapzz. Promote breakthrough products and achieve the impossible.
Applications are invited on plain paper for filling up of position of Junior Research Fellow (Two posts) on a purely temporary basis, in the prescribed proforma. The details of the sponsored project, under which engagement is proposed to be made, are as under.
Filling up of position for engagement as Junior Research Fellow (Two posts) under the Project Code : GAP318526 (Department of Biotechnology, Govt. of India) .
The Tata Memorial Centre (TMC) is an autonomous Grant-in-aid Institution of the Department of Atomic Energy. The TMC is comprised of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) and the Tata Memorial Hospital (TMH). The TMC conducts Ph.D. program in Life Sciences and is affiliated to the Homi Bhabha National Institute (Deemed University). On-going research at TMC includes basic and translational research in Cancer Biology. Specific research topics include study of cell proliferation, differentiation, apoptosis, metastasis, tumor immunology, molecular imaging, carcinogenesis, stem cell biology, biophysics, structural biology, bioinformatics, proteomics, genomics, genetics, epigenetics and Pharmacology.
Applications are invited, in the prescribed format, for the award of JUNIOR RESEARCH FELLOWSHIPS [JRF 2017] for Ph.D. in Life Sciences at Tata Memorial Centre